Close

News

In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229

The activity of a new, terpene-based formulation, code-named NT-VRL-1, against Human Coronavirus (HCoV) strain 229E was evaluated in human lung fibroblasts (MRC-5 cells), with and without the addition of cannabidiol (CBD). The main constituents in the terpene formulation used for the experiment were beta caryophyllene, eucalyptol, and citral. The tested formulation exhibited an antiviral effect […]

Read More...

Practical considerations in medical cannabis administration and dosing

Cannabis has been employed medicinally throughout history, but its recent legal prohibition, biochemical complexity and variability, quality control issues, previous dearth of appropriately powered randomised controlled trials, and lack of pertinent education have conspired to leave clinicians in the dark as to how to advise patients pursuing such treatment. With the advent of pharmaceutical cannabis-based […]

Read More...

Cannabis Therapeutics and the Future of Neurology

Neurological therapeutics have been hampered by its inability to advance beyond symptomatic treatment of neurodegenerative disorders into the realm of actual palliation, arrest or reversal of the attendant pathological processes. While cannabisbased medicines have demonstrated safety, efficacy and consistency sufficient for regulatory approval in spasticity in multiple sclerosis (MS), and in Dravet and Lennox-Gastaut Syndromes […]

Read More...

European Commission reverses position: CBD not a narcotic

The European Commission has reversed its preliminary assessment on CBD, and said the compound is not a narcotic. The reversal comes in the wake of a judgment in which the European Union Court of Justice (ECJ) ruled that CBD cannot be regarded as narcotic, and that CBD products should enjoy the same free movement of goods between and among […]

Read More...

Press release — History made today: UN recognizes medical cannabis

UN recognizes medical cannabis, history made! After 60 years of status quo, 3 years of scientific review by WHO and 2 years of diplomatic discussions, today, the United Nations finally withdrew cannabis from Schedule IV of the Single Convention –the “prohibition schedule”   THE NON-PROFIT FAAAT HAS BEEN ACTIVELY ENGAGED SINCE 2015 TO ENSURE CANNABIS […]

Read More...

We officially launched Flexicann

We officially launched Flexicann in cooperation with Lonza on the Webinar today. You can see the presentations and watch the unique mode of action of UC-II® undenaturated type II collagen here: Why Flexicann®? Unique formula – combination of natural cannabidiol (CBD) mixed with UC-II ® innovative type II collagen and vitamins C, K2, and D Unique […]

Read More...

Interview Scott Blakey: My mother plants are older than my kids

Author: Lukas Hurt You’ve got a really lovely place here in Lugano. Life must be great here. I am hardly ever here, I am travelling basically non-stop because I don’t trust most people, I go straight to the source, I knock on doors and ask questions myself even up to this day. The advantage of […]

Read More...

Scott Blakey: Nejraději vypínám se sluncem

27.09.2019 | TXT: LUKÁŠ HURÝSEK | FOTO: LUKÁŠ HURÝSEK & TEREZA JIRÁSKOVÁ Když se mi naskytla příležitost udělat rozhovor se Scottem Blakeym, kterého celý konopný svět zná pod přezdívkou Shantibaba, neváhal jsem ani minutu. A to i přesto, že to znamenalo výlet „na otočku“ až do švýcarského Lugana. Na terase Scottova domu s dechberoucím výhledem […]

Read More...

Are you more than 18 years of age? Please verify your age to view the content.